Citadel Advisors - ASTRIA THERAPEUTICS INC ownership

ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102. A total of 35 filers reported holding ASTRIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ASTRIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$229,388
+121.5%
30,749
+147.3%
0.00%
Q2 2023$103,584
-68.8%
12,435
-50.2%
0.00%
Q1 2023$332,287
-86.0%
24,984
-84.3%
0.00%
Q4 2022$2,372,662
+114.1%
159,346
+30.1%
0.00%
Q3 2022$1,108,000
+24.1%
122,476
-58.9%
0.00%
Q2 2022$893,000
-69.3%
297,862
-31.2%
0.00%
Q1 2022$2,905,000
+13.7%
432,889
-8.7%
0.00%
Q4 2021$2,556,000
-6.9%
474,273
+52.7%
0.00%
-100.0%
Q3 2021$2,746,000310,5890.00%
Other shareholders
ASTRIA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Altium Capital Management LP 1,355,372$20,181,48910.26%
Fairmount Funds Management LLC 1,901,397$28,311,8014.49%
Tri Locum Partners LP 651,330$9,698,0003.92%
Vivo Capital, LLC 1,681,199$25,0332.88%
Ghost Tree Capital, LLC 450,000$6,701,0002.86%
Affinity Asset Advisors, LLC 472,482$7,035,2572.76%
Ikarian Capital, LLC 675,176$10,053,3702.42%
Cormorant Asset Management, LP 1,650,000$24,5691.64%
Logos Global Management LP 864,960$12,879,2541.51%
SPHERA FUNDS MANAGEMENT LTD. 469,340$6,988,4731.50%
View complete list of ASTRIA THERAPEUTICS INC shareholders